Format

Send to

Choose Destination
Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13.

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study.

Author information

1
Department of Hematology, ASST Spedali Civili, Brescia, Italy.
2
Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Onlus Foundation, Rome, Italy.
3
Hematology Unit-IRCCS Ca' Granda Hospital, Milan, Italy.
4
Department of Hematology DISM-University of Udine, Udine, Italy.
5
Department of Cellular Biotechnology and Hematology-"Sapienza" University, Rome, Italy.
6
Hematology-SS Antonio Hospital, Biagio e C. Arrigo, Alessandria, Italy; and.
7
Hematology Unit, Cardinal Massaia Hospital, Asti, Italy.
PMID:
29898955
DOI:
10.1182/blood-2018-03-835413
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center